The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Mukhacheva D.A.

North-Western State Medical University named after I.I. Mechnikov

Raznatovsky K.I.

North-Western State Medical University named after I.I. Mechnikov

Sobolev A.V.

North-Western State Medical University named after I.I. Mechnikov

Treatment of atopic dermatitis considering assessment of neurotransmitters in blood

Authors:

Mukhacheva D.A., Raznatovsky K.I., Sobolev A.V.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2024;23(4): 368‑376

DOI: 10.17116/klinderma202423041368

Read: 1167 times

Download PDF (RU)
Contact the author
Table of contents

TREATMENT OF ATOPIC DERMATITIS CONSIDERING ASSESSMENT OF NEUROTRANSMITTERS IN BLOOD
TREATMENT OF ATOPIC DERMATITIS CONSIDERING ASSESSMENT OF NEUROTRANSMITTERS IN BLOOD

To cite this article:

Mukhacheva DA, Raznatovsky KI, Sobolev AV. Treatment of atopic dermatitis considering assessment of neurotransmitters in blood. Russian Journal of Clinical Dermatology and Venereology. 2024;23(4):368‑376. (In Russ.)
https://doi.org/10.17116/klinderma202423041368

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Dyna­mics of Substance P and Fila­ggrin Levels on Combined Treatment of Atopic Dermatitis with Emollient and Topi­cal Anti­pruritic Drug in Pregnant Women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):662-666
Atopic dermatitis and skin toxic reactions: comparative characteristics, psychosomatic aspe­cts and patient mana­gement tactics. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):744-752
Labo­ratory biomarkers for the prognosis of chro­nic heart failure. Labo­ratory Service. 2024;(3):5-16
Gut microbiota: role in human health and pote­ntial for personalized medi­cine. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):81-88
The role of immuno-inflammatory factors in the deve­lopment of nega­tive symptoms in schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):42-48
Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72
Inflammatory aging. Part 1. The principal biochemical mechanisms. Russian Journal of Preventive Medi­cine. 2024;(12):145-150
Prognosis and prevention of recu­rrent and atypical endo­metrial hype­rplasia in women of reproductive age. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):59-65
Inflammatory aging. Part 2. Are there diagnostic biomarkers available. Russian Journal of Preventive Medi­cine. 2025;(1):89-95
The expe­rience of diagnosing Alzheimer’s disease based on the study of cere­brospinal fluid biomarkers. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):91-97
Abstract:

Atopic dermatitis (AD) is a disease manifested by intense itching and impaired barrier functions of the skin. Itching occurs when the nerve endings of the skin are activated by various inflammation mediators, neurotransmitters and neuropeptides.

OBJECTIVE

To systematize information about the role of neurotransmitters as markers of AD exacerbation, to assess their indices in blood in patients during therapy, to identify predictors of AD remission achievement by patient.

MATERIAL AND METHODS

Clinical laboratory examination of 168 patients with AD (42% male, 72.8% female) was carried out, among whom 127 persons with moderate to severe AD were identified (SCORAD >50). Predictors of patient’s achievement of mild AD have been identified and a model of logical regression has been developed.

RESULTS

A variable change of neurotransmitters in the blood serum has been revealed in patients in case of AD exacerbation. It has been established that the mean serotonin concentration was 107.8±50.1 ng/ml, median 102.4 (73.7; 134.3) ng/ml, reference values (RA) 36.0—82.0 ng/ml. A logistic regression model has been developed in the examination of 127 patients with moderate to severe AD (SCORAD >50). Serotonin has been found to be a significant (p=0.009) predictor for achieving the clinical effect of therapy along with SCORAD and patient age.

CONCLUSION

The obtained results can serve as diagnostic criteria for development of the most rational AD therapy considering the changes in the concentration of neurotransmitters in the blood serum.

Keywords:

atopic dermatitis
microbiome
biomarkers
neurotransmitters

Authors:

Mukhacheva D.A.

North-Western State Medical University named after I.I. Mechnikov

Raznatovsky K.I.

North-Western State Medical University named after I.I. Mechnikov

Sobolev A.V.

North-Western State Medical University named after I.I. Mechnikov

Received:

30.01.2024

Accepted:

02.07.2024

Close metadata

References:

  1. Musters AH, Mashayekhi S, Harvey J, Axon E, Lax SJ, Flohr C, Drucker AM, Gerbens L, Ferguson J, Ibbotson S, Dawe RS, Garritsen F, Brouwer M, Limpens J, Prescott LE, Boyle RJ, Spuls PI. Phototherapy for atopic eczema. Cochrane Database Syst Rev. 2021;10(10):CD013870. PMID: 34709669; PMCID: PMC8552896. https://doi.org/10.1002/14651858.CD013870.pub2
  2. Deleanu D, Nedelea I. Biological therapies for atopic dermatitis: An update. Exp Ther Med. 2019;17(2):1061-1067. Epub 2018 Nov 19. PMID: 30679974; PMCID: PMC6327672. https://doi.org/10.3892/etm.2018.6989
  3. Chen Y, Chen W. Genome-Wide Integration of Genetic and Genomic Studies of Atopic Dermatitis: Insights into Genetic Architecture and Pathogenesis. J Invest Dermatol. 2022;142(11):2958-2967.e8. Epub 2022 May 14. PMID: 35577104. https://doi.org/10.1016/j.jid.2022.04.021
  4. Katunina OR, Chikin VV, Znamenskaya LF, Inoyatova LA. Role of neuromediators in the development of skin inflammation in patients with atopic dermatitis. Vestnik dermatologii i venerologii. 2013;89(5):91-101. (In Russ.). https://doi.org/10.25208/vdv575
  5. Wang F, Trier AM, Li F, Kim S, Chen Z, Chai JN, Mack MR, Morrison SA, Hamilton JD, Baek J, Yang TB, Ver Heul AM, Xu AZ, Xie Z, Dong X, Kubo M, Hu H, Hsieh CS, Dong X, Liu Q, Margolis DJ, Ardeleanu M, Miller MJ, Kim BS. A basophil-neuronal axis promotes itch. Cell. 2021;184(2): 422-440.e17. Epub 2021 Jan 14. PMID: 33450207; PMCID: PMC7878015. https://doi.org/10.1016/j.cell.2020.12.033
  6. Orlova EA, Kandrashkina JuA, Kostina EM. Neuroimmune interactions in the pathogenesis of atopic dermatitis: the current state of the problem. Farmateka. 2021;28(8):27-33. (In Russ.). https://doi.org/10.18565/pharmateca.2021.8.27-33
  7. Smolyannikova VA, Kubanova AA, Karamova AE, Nefedova MA, Chikin VV. Role of the skin expression of neuropeptides, neurotrophins and their receptors in the pathogenesis of dermatoses. Russian Journal of Archive of Pathology. 2015;77(4):33-39. PMID: 26485778. (In Russ.). https://doi.org/10.17116/patol201577433-39
  8. Shandra AA, Shukhtin VV. Atopic dermatitis and the interaction of the nervous, endocrine and immune systems. Dermatologiya ta venerologiya. 2015; 2(68):30-41. (In Russ.).
  9. Szilveszter KP, Németh T, Mócsai A. Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases. Front Immunol. 2019;10:1862. PMID: 31447854; PMCID: PMC6697022. https://doi.org/10.3389/fimmu.2019.01862
  10. Sun PY, Li HG, Xu QY, Zhang Z, Chen JW, Shen YH, Qi X, Lu JF, Tan YD, Wang XX, Li CX, Yang MY, Ma YZ, Lu Y, Xu TL, Shen JW, Li WG, Guo YF, Yao ZR. Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons. Br J Pharmacol. 2023;180(10):1339-1361. Epub 2023 Jan 08. PMID: 36521846. https://doi.org/10.1111/bph.16012
  11. Losasso V, Agarwal K, Waskar M, Majumdar A, Crain J, Winn M, Hoptroff M. Small molecules enhance the potency of natural antimicrobial peptides. Biophys J. 2022;121(3):491-501. Epub 2021 Dec 24. PMID: 34954157; PMCID: PMC8822605. https://doi.org/10.1016/j.bpj.2021.12.029
  12. Key FM, Khadka VD, Romo-González C, Blake KJ, Deng L, Lynn TC, Lee JC, Chiu IM, García-Romero MT, Lieberman TD. On-person adaptive evolution of Staphylococcus aureus during treatment for atopic dermatitis. Cell Host Microbe. 2023;31(4):593-603.e7. PMID: 37054679; PMCID: PMC10263175. https://doi.org/10.1016/j.chom.2023.03.009
  13. Climent E, Martinez-Blanch JF, Llobregat L, Ruzafa-Costas B, Carrión-Gutiérrez MÁ, Ramírez-Boscá A, Prieto-Merino D, Genovés S, Codoñer FM, Ramón D, Chenoll E, Navarro-López V. Changes in Gut Microbiota Correlates with Response to Treatment with Probiotics in Patients with Atopic Dermatitis. A Post Hoc Analysis of a Clinical Trial. Microorganisms. 2021;9(4):854. PMID: 33921166; PMCID: PMC8071520. https://doi.org/10.3390/microorganisms9040854
  14. Li Y, Chen L, Du Y, Huang D, Han H, Dong Z. Fluoxetine Ameliorates Atopic Dermatitis-Like Skin Lesions in BALB/c Mice through Reducing Psychological Stress and Inflammatory Response. Front Pharmacol. 2016; 7:318. PMID: 27679577; PMCID: PMC5020056. https://doi.org/10.3389/fphar.2016.00318
  15. Aberg KM, Radek KA, Choi EH, Kim DK, Demerjian M, Hupe M, Kerbleski J, Gallo RL, Ganz T, Mauro T, Feingold KR, Elias PM. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest. 2007;117(11):3339-3349. PMID: 17975669; PMCID: PMC2045593. https://doi.org/10.1172/JCI31726
  16. Hanoodi M, Mittal M. Methotrexate. 2023 Aug 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. PMID: 32310574.
  17. Muhacheva DA, Raznatovskij KI. Changes in the content of neurotransmitters in the blood serum of patients with atopic dermatitis. Problemy meditsinskoj mikologii. 2022;24(2):106. (In Russ.).
  18. Desmet SJ, De Bosscher K. Glucocorticoid receptors: finding the middle ground. J Clin Invest. 2017;127(4):1136-1145. Epub 2017 Mar 20. PMID: 28319043; PMCID: PMC5373866. https://doi.org/10.1172/JCI88886
  19. Thibodeaux Q, Smith MP, Ly K, Beck K, Liao W, Bhutani T. A review of dupilumab in the treatment of atopic diseases. Hum Vaccin Immunother. 2019;15(9):2129-2139. Epub 2019 Mar 27. PMID: 30785362; PMCID: PMC6773424. https://doi.org/10.1080/21645515.2019.1582403
  20. Balevi A, Üstüner P, Kakşi SA, Özdemir M. Narrow-band UV-B phototherapy: an effective and reliable treatment alternative for extensive and recurrent pityriasis versicolor. J Dermatolog Treat. 2018;29(3):252-255. Epub 2017 Nov 09. PMID: 28984153. https://doi.org/10.1080/09546634.2017.1364690
  21. Ahmed Asim S, Ahmed S, Us-Sehar N. Psoralen-ultraviolet A treatment with Psoralen-ultraviolet B therapy in the treatment of psoriasis. Pak J Med Sci. 2013;29(3):758-761. PMID: 24353623; PMCID: PMC3809278. https://doi.org/10.12669/pjms.293.2622
  22. Yu J, Luo Y, Zhu Z, Zhou Y, Sun L, Gao J, Sun J, Wang G, Yao X, Li W. A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor. J Allergy Clin Immunol. 2019;143(6):2108-2119.e12. Epub 2018 Dec 20. PMID: 30578876. https://doi.org/10.1016/j.jaci.2018.11.036
  23. Fang Z, Li L, Liu X, Lu W, Zhao J, Zhang H, Chen W. Strain-specific ameliorating effect of Bifidobacterium longum on atopic dermatitis in mice. Journal of Functional Foods. 2019;60:103426. ISSN 1756-4646. https://doi.org/10.1016/j.jff.2019.103426
  24. Fang Z, Pan T, Li L, Wang H, Zhu J, Zhang H, Zhao J, Chen W, Lu W. Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis. Gut Microbes. 2022;14(1):2044723. PMID: 35239463; PMCID: PMC8903757. https://doi.org/10.1080/19490976.2022.2044723
  25. Zinkevičienė A, Kainov D, Girkontaitė I, Lastauskienė E, Kvedarienė V, Fu Y, Anders S, Velagapudi V. Activation of Tryptophan and Phenylalanine Catabolism in the Remission Phase of Allergic Contact Dermatitis: A Pilot Study. Int Arch Allergy Immunol. 2016;170(4):262-268. Epub 2016 Oct 22. PMID: 27771694. https://doi.org/10.1159/000450789
  26. Maffei ME. 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int J Mol Sci. 2020;22(1):181. PMID: 33375373; PMCID: PMC7796270. https://doi.org/10.3390/ijms22010181
  27. Rasul A, El-Nour H, Lonne-Rahm SB, Fransson O, Johansson C, Johansson B, Zubeidi M, Seeberg E, Djurfeldt DR, Azmitia EC, Nordlind K. Serotonergic Markers in Atopic Dermatitis. Acta Derm Venereol. 2016;96(6): 732-736. PMID: 26831833. https://doi.org/10.2340/00015555-2354
  28. Beyer L, Kabatas AS, Mommert S, Stark H, Werfel T, Gutzmer R, Schaper-Gerhardt K. Histamine Activates Human Eosinophils via H2R and H4R Predominantly in Atopic Dermatitis Patients. Int J Mol Sci. 2022;23(18): 10294. PMID: 36142206; PMCID: PMC9499661. https://doi.org/10.3390/ijms231810294
  29. Schjødt MS, Gürdeniz G, Chawes B. The Metabolomics of Childhood Atopic Diseases: A Comprehensive Pathway-Specific Review. Metabolites. 2020; 10(12):511. PMID: 33339279; PMCID: PMC7767195. https://doi.org/10.3390/metabo10120511
  30. Szelest M, Walczak K, Plech T. A New Insight into the Potential Role of Tryptophan-Derived AhR Ligands in Skin Physiological and Pathological Processes. Int J Mol Sci. 2021;22(3):1104. PMID: 33499346; PMCID: PMC7865493. https://doi.org/10.3390/ijms22031104
  31. Kiecka A, Szczepanik M. The potential action of SSRIs in the treatment of skin diseases including atopic dermatitis and slow-healing wounds. Pharmacol Rep. 2022;74(5):947-955. Epub 2022 Oct 07. PMID: 36203121; PMCID: PMC9584846. https://doi.org/10.1007/s43440-022-00423-7
  32. Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS, Eichenfield LF, Forsha DW, Rees WC, Simpson EL, Spellman MC, Stein Gold LF, Zaenglein AL, Hughes MH, Zane LT, Hebert AA. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016;75(3):494-503.e6. Epub 2016 July 11. Erratum in: J Am Acad Dermatol. 2017;76(4):777. PMID: 27417017. https://doi.org/10.1016/j.jaad.2016.05.046
  33. Montes-Torres A, Llamas-Velasco M, Pérez-Plaza A, Solano-López G, Sánchez-Pérez J. Biological Treatments in Atopic Dermatitis. J Clin Med. 2015;4(4):593-613. PMID: 26239349; PMCID: PMC4470158. https://doi.org/10.3390/jcm4040593
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.